American Society of Clinical Oncology

Reminder: The @conquercancer.bsky.social Career Development Award in #TNBC deadline is approaching! This mentored award supports U.S. clinical investigators building an independent research career.

Submit your application by March 12th: https://bit.ly/3NO6vYt
#OncologyResearch

Attention early-career oncologists! There's still time to apply for the @ConquerCancerFd YIA in Primary Brain Tumors. This mentored award supports your transition from fellowship to faculty.

Apply by March 12th: https://bit.ly/4rhR8pn
#OncTwitter #ResearchFunding

This #WorldCancerDay, join we & Ain Shams University Hospital for a free webinar w/global leaders & early-career professionals as we discuss professional development & collaboration across Arab and African regions.

Register today: bit.ly/46ecHz3
#WCD #ASCOGlobalImpact

Don’t miss the 2026 Medical Oncology In-Training Exam on Feb. 24 & 25! This proctored, Internet-based exam is a great way to track trainee progress across key domains. Discounts available.

Learn more & register: shorturl.at/aAOkI

Our current cycle of funding uncertainty puts decades of progress at risk & will cost researchers & patients alike.

We thank the House for passing the FY26 LHHS funding bill & urge the Senate to follow suit: brnw.ch/21wZkOT
#SaveResearchStopCancer #ASCOAdvocacy

ASCO Edge, an online operations management educational series, has released a new module: Navigating Employment Agreements. Providing all oncologists with education & the tools to effectively manage the business side of their practices.

Learn more: brnw.ch/21wZiM5

his year, our LDP has expanded to Central & Eastern Europe! This program will connect oncology professionals in the region to collaborate & learn practical skills. Review eligibility requirements & apply for the 2026-27 program by March 10: brnw.ch/21wZgQh

New @ascocancer.bsky.social mCRPC living guideline updated recommendations for systemic therapy are here! For patients w/ visceral metastases (lung/liver), enzalutamide or docetaxel is advised, regardless of HRR status.

Stay current on mCRPC care: brnw.ch/21wZfuI

Stable federal funding is about more than discovering future innovations. Uncertainty is driving delays in clinical trials that mean patients are left waiting for the potential breakthrough they desperately need.

Learn more: brnw.ch/21wZfk4
#SaveResearchStopCancer #ASCOAdvocacy

Get a first look at the high-impact data on the study, diagnosis, and treatment of GU malignancies that will be featured at this year’s #GU26 and browse our just-released abstract titles: tinyurl.com/2mzsrp79

Registration is still open, so join us in person or online: tinyurl.com/5ecd4wxe

If you haven’t yet watched the #GI26 Keynote by Dr. W. Kimryn Rathmell, “Meeting Patients With Cancer Where They Are—The Role of Dyad Partnerships in Oncology,” it’s now available to all: brnw.ch/21wZ9GS

Applications are OPEN! Medical institutions in Asia Pacific LMICs: Apply to be an ASCO International Cancer Corps (ICC) Site. Improve clinical staff's expertise in cancer management, palliative care, and quality measures.

Apply by March 31, 2026: brnw.ch/21wZ9ui
#ASCOGlobalImpact

🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social & @viveksubbiah.bsky.social of Sarah Cannon Research Institute discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education #BytheBook Podcast. url-shortener.me/820P
#ASCOEdBook

We congratulate 2018-19 ASCO President Dr. Monica Bertagnolli on her election as President of the @nam.edu.

ICYMI at #GI26: 2 novel KRAS-targeted treatments demonstrated manageable safety profiles and promising efficacy in early-phase studies of patients w/ PDAC and KRAS G12D mutations.

#ASCODailyNews has more: brnw.ch/21wZ79x

Boost your training w/ the 2026 Medical Oncology In-Training Exam (Feb. 24-25)—registration is open! This low-stakes, proctored exam is intended for self-evaluation and program improvement.

Discounts offered. Get details & register today: brnw.ch/21wZ5vL

Don’t miss your chance to share your high-impact oncology data at #ASCO26! Be heard & be a part of driving advancements in the field, inspiring new solutions to improve outcomes for all people with cancer.

Abstracts due Jan. 27 at 11:59 pm (ET): asco.confex.com/asco/2026/cf...

Unpredictable federal funding is accelerating a cancer “brain drain,” pushing top American talent to international competitors.

Congress must provide sustained funding to support the next gen of research innovators: brnw.ch/21wZ1G3
#SaveResearchStopCancer #ASCOAdvocacy

Now that #GI26 is over, catch up on all the news from the meeting with #ASCODailyNews. All coverage of the Symposium's top research can be found here: brnw.ch/21wZ1z3

Get ready for 3 days of high-impact scientific & ed. sessions & case-based discussions on global oncology advances w/ insights from regional experts @ 2026 ASCO Breakthrough.

Registration is open, so join us in Singapore, June 25-27: brnw.ch/21wZ1ju
#ASCOBT26

It was wonderful meeting many of our #GI26 Featured Voices in person! A huge ‘thank you’ to ALL of you for lending your time & expertise to help digest symposium findings and provide key takeaways. We couldn’t do it without you!

@mpishvaian.bsky.social @drkatepedersen.bsky.social

As the sun sets in San Francisco and #GI26 comes to a close, we reflect with gratitude on the 3 days we spent with all of you, in person and online. Three full days of learning and connecting, making progress on treatments and care for patients with GI cancers. #gicsm

asco.org/gi-program

It's the final session of #GI26, Multidisciplinary Tumor Board: Innovations in Management of T2 Rectal Cancer” chaired by Dr. Jacquelyne Janean Gaddy & Dr. Montserrat Guraieb-Trueba, reviewing clinical case scenarios: meetings.asco.org/meetings/202...
#crcsm

Thank you Sydney Towle for sharing your experiences and insights with the @ASCO GI #GI26 community.
Your powerful words are heard and understood.

Oral Abstract Session C: Cancer of the Colon, Rectum, and Anus, happening now at #GI26, is full of the latest science in these disease areas, including three abstracts featured in the press program (nos. 13, 14 & 16). meetings.asco.org/meetings/202...

@skopetz.bsky.social

Another packed breakout session here at #GI26! Learning how to optimize colorectal cancer treatment through ctDNA, happening now: meetings.asco.org/meetings/202...

#crcsm

Learning about selection criteria & advances in liver-directed therapies & debating role of liver transplantation to improve pt outcomes @ #GI26 Liver-Directed Approaches and Transplantation for Unresectable Colorectal Liver Metastasis session happening now: meetings.asco.org/meetings/202... #gicsm

Happening now at #GI26: Rapid Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus. #crcsm #ancsm meetings.asco.org/meetings/202...

This session includes a press program abstract on GLP-1 receptor agonists as potential cancer prevention Tx strategy: www.asco.org/about-asco/p...

The 3rd & final intersections session of #GI26 is happening now: “Navigating Early-Onset Gastrointestinal Cancers—From Diagnosis to Survivorship” chaired by Dr. David Shibata and Dr. Wojciech Blogowski. #gicsm

meetings.asco.org/meetings/202...

Good morning from #GI26! Join us for posters & a complimentary continental breakfast from 7-8 AM (PT). 🥐☕ Sip your coffee and view the posters and trials in progress posters on science & findings re: cancers of the colon, rectum & anus. asco.org/gi-program

#crcsm #ancsm